ConductScience.org, home

Paper21622860

Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.

Long HM and 7 others. J Immunol, 2011. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. Papers, record 21622860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21622860

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
PubMed
Journal
J Immunol
PubMed
Year
2011
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
1.49
iCite
Revised in PubMed
2025-05-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Long HMHeather M
2Leese AMAlison M
3Chagoury OLOdette L
4Connerty SRShawn R
5Quarcoopome JJared
6Quinn LLLaura L
7Shannon-Lowe CClaire
8Rickinson ABAlan B

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4-Positive T-LymphocytesMajor topic
CD8-Positive T-LymphocytesMajor topic
Cytotoxicity Tests, ImmunologicMajor topic
Gene Expression Regulation, ViralMajor topic
Herpesvirus 4, HumanMajor topic
Virus ReplicationMajor topic
Antigens, Viral
Cells, Cultured
Clone Cells
Epitope Mapping
Epitopes, T-Lymphocyte
Humans
Immediate-Early Proteins
Interferon-gamma
Phosphoproteins
Trans-Activators

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G0901755-E02/1Medical Research CouncilUnited KingdomPubMed
G0901755Medical Research CouncilUnited KingdomPubMed
G0901755-E02/1PHS HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18053055Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.Transplantation1994https://conductscience.org/library/papers/8053055PubMed
211507210Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.J Virol2001https://conductscience.org/library/papers/11507210PubMed
312975456Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.J Exp Med2003https://conductscience.org/library/papers/12975456PubMed
412134023The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.J Virol2002https://conductscience.org/library/papers/12134023PubMed
519605492Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.J Virol2009https://conductscience.org/library/papers/19605492PubMed
616147978Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.J Exp Med2005https://conductscience.org/library/papers/16147978PubMed
717378764Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.Annu Rev Immunol2007https://conductscience.org/library/papers/17378764PubMed
812165547Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope.J Immunol2002https://conductscience.org/library/papers/12165547PubMed
915310471The immune response to Epstein-Barr virus.Microbes Infect2004https://conductscience.org/library/papers/15310471PubMed
1020385879Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.J Immunol2010https://conductscience.org/library/papers/20385879PubMed
1115307182Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.Eur J Immunol2004https://conductscience.org/library/papers/15307182PubMed
1215919916Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative epstein-barr virus.J Virol2005https://conductscience.org/library/papers/15919916PubMed
1316549597Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.J Exp Med2006https://conductscience.org/library/papers/16549597PubMed
1420133861Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20133861PubMed
151710291Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.J Virol1991https://conductscience.org/library/papers/1710291PubMed
1619439479Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.J Virol2009https://conductscience.org/library/papers/19439479PubMed
1710856251The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.EMBO J2000https://conductscience.org/library/papers/10856251PubMed
1815827162Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.J Virol2005https://conductscience.org/library/papers/15827162PubMed
1915795275CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.J Virol2005https://conductscience.org/library/papers/15795275PubMed
208553567
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Virology1995https://conductscience.org/library/papers/8553567PubMed

See all 49 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
41034205Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19.Nat Commun2025https://conductscience.org/library/papers/41034205PubMed
39776919EBV-specific T-cell immunity: relevance for multiple sclerosis.Front Immunol2024https://conductscience.org/library/papers/39776919PubMed
39505801Research landmarks on the 60th anniversary of Epstein-Barr virus.Sci China Life Sci2025https://conductscience.org/library/papers/39505801PubMed
39346922Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice.Front Immunol2024https://conductscience.org/library/papers/39346922PubMed
38179040Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival.Front Immunol2023https://conductscience.org/library/papers/38179040PubMed
37865406
Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised children.
BMJ Open2023https://conductscience.org/library/papers/37865406PubMed
36456735Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition.Nat Immunol2022https://conductscience.org/library/papers/36456735PubMed
36077655Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells.Cancers (Basel)2022https://conductscience.org/library/papers/36077655PubMed
35686929Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy.Clin Cancer Res2022https://conductscience.org/library/papers/35686929PubMed
34882759Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors.PLoS Pathog2021https://conductscience.org/library/papers/34882759PubMed
34668039CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes.Cancer Immunol Immunother2022https://conductscience.org/library/papers/34668039PubMed
34638238Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection.Cancers (Basel)2021https://conductscience.org/library/papers/34638238PubMed
34068598Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus.Cancers (Basel)2021https://conductscience.org/library/papers/34068598PubMed
33901176The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek's disease virus peptides by using an unprecedented binding motif.PLoS Biol2021https://conductscience.org/library/papers/33901176PubMed
33662046PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity.PLoS Pathog2021https://conductscience.org/library/papers/33662046PubMed
33658348T cell epitope screening of Epstein-Barr virus fusion protein gB.J Virol2021https://conductscience.org/library/papers/33658348PubMed
33102204Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals.Front Oncol2020https://conductscience.org/library/papers/33102204PubMed
32461311The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4+ T Cells.J Virol2020https://conductscience.org/library/papers/32461311PubMed
31620125The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog.Front Immunol2019https://conductscience.org/library/papers/31620125PubMed
31308093Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells.J Immunol2019https://conductscience.org/library/papers/31308093PubMed

See all 49 cited byDownload CSV of cited by

Genes22

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AATF26574PubTator's text mininghttps://conductscience.org/library/genes/26574NCBI Gene
CCR71236PubTator's text mininghttps://conductscience.org/library/genes/1236NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
FRK2444PubTator's text mininghttps://conductscience.org/library/genes/2444NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-DPB13115PubTator's text mininghttps://conductscience.org/library/genes/3115NCBI Gene
HLA-DQB13119PubTator's text mininghttps://conductscience.org/library/genes/3119NCBI Gene
HLA-DRB13123PubTator's text mininghttps://conductscience.org/library/genes/3123NCBI Gene
HLA-DRB33125PubTator's text mininghttps://conductscience.org/library/genes/3125NCBI Gene
HLA-DRB53127PubTator's text mininghttps://conductscience.org/library/genes/3127NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
LAMP13916PubTator's text mininghttps://conductscience.org/library/genes/3916NCBI Gene
LTA4049PubTator's text mininghttps://conductscience.org/library/genes/4049NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene

See all 22 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21622860

GET https://conductscience.org/api/papers/v1/21622860/references?page=2